StockNews.AI
AIP
StockNews.AI
203 days

Arteris Announces New Employment Inducement Grants

1. Arteris granted 80,000 RSUs to four new employees. 2. The RSU grants comply with Nasdaq rules. 3. This move may enhance employee retention and attract talent. 4. Arteris focuses on SoC development efficiency. 5. Investors may view this positively for future growth.

3m saved
Insight
Article

FAQ

Why Bullish?

Employee RSU grants can improve retention and performance, similar to past successful grants.

How important is it?

Employee incentives generally boost long-term company performance and investor confidence.

Why Short Term?

Immediate impact on employee morale and retention, influencing short-term performance.

Related Companies

AIP
January 28, 2025 16:45 ET  | Source: Arteris, Inc. CAMPBELL, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading provider of system IP which accelerates system-on-chip (SoC) creation, today announced that the compensation committee of the company’s board of directors has granted an aggregate of 80,000 restricted stock units (RSUs) to four newly hired employees as inducement awards under the company’s 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4). The effective RSU grant date was January 23, 2025, and it was approved by the company’s board of directors. About Arteris Arteris is a leading provider of system IP for the acceleration of system-on-chip (SoC) development across today’s electronic systems. Arteris network-on-chip (NoC) interconnect IP and SoC integration technology enable higher product performance with lower power consumption and faster time to market, delivering better SoC economics so its customers can focus on dreaming up what comes next. Learn more at arteris.com. © 2004-2025 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners. Media Contact:Gina JacobsArteris+1 408 560 3044newsroom@arteris.com Investor Relations Contact:Sapphire Investor Relations, LLCErica Mannion or Mike Funari+1 617 542 6180ir@arteris.com

Related News